Ver registro no DEDALUS
Exportar registro bibliográfico



Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A2: activation of endogenous phospholipases contributes to the pronociceptive effect (2017)

  • Authors:
  • USP affiliated authors: CUNHA, FERNANDO DE QUEIROZ - FMRP
  • USP Schools: FMRP
  • DOI: 10.1186/s40409-017-0104-0
  • Keywords: Lys49-PLA2; Myotoxin II; Arthritis; Bothrops asper; Phospholipase
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/s40409-017-0104-0 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      DIAS, Renata Gonçalves; SAMPAIO, Sandra Coccuzzo; SANT’ANNA, Morena Brazil; et al. Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A2: activation of endogenous phospholipases contributes to the pronociceptive effect. Journal of Venomous Animals and Toxins including Tropical Diseases, London, v. 23, p. 13 , 2017. Disponível em: < > DOI: 10.1186/s40409-017-0104-0.
    • APA

      Dias, R. G., Sampaio, S. C., Sant’Anna, M. B., Cunha, F. de Q., Gutiérrez, J. M., Lomonte, B., et al. (2017). Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A2: activation of endogenous phospholipases contributes to the pronociceptive effect. Journal of Venomous Animals and Toxins including Tropical Diseases, 23, 13 . doi:10.1186/s40409-017-0104-0
    • NLM

      Dias RG, Sampaio SC, Sant’Anna MB, Cunha F de Q, Gutiérrez JM, Lomonte B, Cury Y, Picolo G. Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A2: activation of endogenous phospholipases contributes to the pronociceptive effect [Internet]. Journal of Venomous Animals and Toxins including Tropical Diseases. 2017 ; 23 13 .Available from:
    • Vancouver

      Dias RG, Sampaio SC, Sant’Anna MB, Cunha F de Q, Gutiérrez JM, Lomonte B, Cury Y, Picolo G. Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A2: activation of endogenous phospholipases contributes to the pronociceptive effect [Internet]. Journal of Venomous Animals and Toxins including Tropical Diseases. 2017 ; 23 13 .Available from:

    Referências citadas na obra
    Centers for Disease Control and Prevention (CDC). Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation--United States, 2010–2012. Morb Mortal Wkly Rep. 2013;62(44):869–73.
    Centers for Disease Control and Prevention. Arthritis Improving the Quality of Life for People With Arthritis. At a glance 2016. Natl Cent Chronic Dis Prev Heal Promot. GA, USA. 2016. .
    Niedermeier M, Pap T, Korb A. Therapeutic opportunities in fibroblasts in inflammatory arthritis. Best Pract Res Clin Rheumatol. 2010;24(4):527–40.
    Choi SI, Brahn E. Rheumatoid arthritis therapy: advances from bench to bedside. Autoimmunity. 2010;43(7):478–92.
    Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges. Bone. 2016;85:81–90.
    Murakami M, Taketomi Y, Sato H, Yamamoto K. Secreted phospholipase A2 revisited. J Biochem. 2011;150(3):233–55.
    Mouchlis VD, Dennis EA. Membrane and inhibitor interactions of intracellular phospholipases A2. Adv Biol Regul. 2016;61:17–24.
    Hegen M, Sun L, Uozumi N, Kume K, Goad ME, Nickerson-Nutter CL, et al. Cytosolic Phospholipase A2α-deficient Mice Are Resistant to Collagen-induced Arthritis. J Exp Med. 2003;197(10):1297–302.
    Leistad L, Feuerherm AJ, Ostensen M, Faxvaag A, Johansen B. Presence of secretory group IIa and V phospholipase A2 and cytosolic group IVα phospholipase A2 in chondrocytes from patients with rheumatoid arthritis. Clin Chem Lab Med. 2004;42(6):602–10.
    Tai N, Kuwabara K, Kobayashi M, Yamada K, Ono T, Seno K, et al. Cytosolic phospholipase A2 alpha inhibitor, pyrroxyphene, displays anti-arthritic and anti-bone destructive action in a murine arthritis model. Inflamm Res. 2010;59(1):53–62.
    Kumar LD, Karthik R, Gayathri N, Sivasudha T. Advancement in contemporary diagnostic and therapeutic approaches for rheumatoid arthritis. Biomed Pharmacother. 2016;79:52–61.
    Gavrilă BI, Ciofu C, Stoica V. Biomarkers in Rheumatoid Arthritis, what is new? J Med Life. 2016;9(2):144–8.
    Weiss PF. Update on enthesitis-related arthritis. Curr Opin Rheumatol. 2016;28(5):530–6.
    Welker S, Markert Y, Koditz J, Mansfeld J, Ulbrich-Hofmann R. Disulfide bonds of phospholipase A2 from bee venom yield discrete contributions to its conformational stability. Biochimie. 2011;93(2):195–201.
    Six DA, Dennis EA. The expanding superfamily of phospholipase A2 enzymes: Classification and characterization. Biochim Biophys Acta. 2000;1488(1–2):1–19.
    Huang TF, Chiang HS. Effect on human platelet aggregation of phospholipase A2 purified from Heloderma horridum (beaded lizard) venom. Biochim Biophys Acta. 1994;1211(1):61–8.
    Mansfeld J. Plant phospholipases A2: perspectives on biotechnological applications. Biotechnol Lett. 2009;31(9):1373–80.
    Santos LD, Pieroni M, Menegasso ARS, Pinto JRAS, Palma MS. A new scenario of bioprospecting of Hymenoptera venoms through proteomic approach. J Venom Anim Toxins incl Trop Dis. 2011;17(3):364–77.
    Ramírez-Avila J, Quevedo BE, López E, Renjifo JM. Purification and partial characterization of phospholipases A2 from Bothrops asper (barba amarilla) snake venom from Chiriguaná (Cesar, Colombia). J Venom Anim Toxins incl Trop Dis. 2004;10(3):242–59.
    Angulo Y, Lomonte B. Biochemistry and toxicology of toxins purified from the venom of the snake Bothrops asper. Toxicon. 2009;54(7):949–57.
    Lomonte B, Carmona E. Individual expression patterns of myotoxin isoforms in the venom of the snake Bothrops asper. Comp Biochem Physiol B. 1992;102:325–9.
    Gutiérrez JM, Lomonte B. Phospholipase A2 myotoxins from Bothrops snake venoms. Toxicon. 1995;33(11):1405–24.
    Teixeira C, Cury Y, Moreira V, Picolo G, Chaves F. Inflammation induced by Bothrops asper venom. Toxicon. 2009;54(1):67–76.
    Zuliani JP, Fernandes CM, Zamuner SR, Gutiérrez JM, Teixeira CF. Inflammatory events induced by Lys-49 and Asp-49 phospholipases A2 isolated from Bothrops asper snake venom: role of catalytic activity. Toxicon. 2005;45(3):335–46.
    Moreira V, Gutiérrez JM, Soares AM, Zamunér SR, Purgatto E, Teixeira CF. Secretory phospholipases A2 isolated from Bothrops asper and from Crotalus durissus terrificus snake venoms induce distinct mechanisms for biosynthesis of prostaglandins E2 and D2 and expression of cyclooxygenases. Toxicon. 2008;52(3):428–39.
    Moreira V, de Castro Souto PC, Ramirez Vinolo MA, Lomonte B, Gutiérrez JM, Curi R, et al. A catalytically-inactive snake venom Lys49 phospholipase A2 homolog induces expression of cyclooxygenase-2 and production of prostaglandins through selected signaling pathways in macrophages. Eur J Pharmacol. 2013;708(1–3):68–79.
    Teixeira CF, Landucci EC, Antunes E, Chacur M, Cury Y. Inflammatory effects of snake venom myotoxic phospholipases A2. Toxicon. 2003;42(8):947–62.
    Chacur M, Longo I, Picolo G, Gutiérrez JM, Lomonte B, Guerra JL, et al. Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: pharmacological mediation and molecular determinants. Toxicon. 2003;41(6):667–78.
    Chacur M, Milligan ED, Sloan EM, Wieseler-Frank J, Barrientos RM, Martin D, et al. Snake venom phospholipase A2s (Asp49 and Lys49) induce mechanical allodynia upon peri-sciatic administration: involvement of spinal cord glia, proinflammatory cytokines and nitric oxide. Pain. 2004;108(1–2):180–91.
    Lomonte B, Gutiérrez JM. A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). Toxicon. 1989;27(7):725–33.
    Tonussi CR, Ferreira SH. Rat knee-joint carrageenin incapacitation test: an objective screen for central and peripheral analgesics. Pain. 1992;48(3):421–7.
    Ekundi-Valentim E, Santos KT, Camargo EA, Denadai-Souza A, Teixeira SA, Zanoni CI, et al. Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat. Br J Pharmacol. 2010;159(7):1463–74.
    Guerrero AT, Verri WA, Cunha TM, Silva TA, Schivo IR, Dal-Secco D, et al. Involvement of LTB4 in zymosan-induced joint nociception in mice: participation of neutrophils and PGE2. J Leukoc Biol. 2008;83(1):122–30.
    Guerrero AT, Verri Jr WA, Cunha TM, Silva TA, Rocha FA, Ferreira SH, et al. Hypernociception elicited by tibio-tarsal joint flexion in mice: a novel experimental arthritis model for pharmacological screening. Pharmacol Biochem Behav. 2006;84(2):244–51.
    Freysdottir J, Hardardottir I, Gizurarson S, Vikingsson A. Mucosal tolerance to KLH reduces BSA-induced arthritis in rats--an indication of bystander suppression. J Clin Immunol. 2007;27(3):284–93.
    Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78(3):206–9.
    Sampaio SC, Brigatte P, Sousa-e-Silva MC, dos-Santos EC, Rangel-Santos AC, Curi R, et al. Contribution of crotoxin for the inhibitory effect of Crotalus durissus terrificus snake venom on macrophage function. Toxicon. 2003;41(7):899–907.
    Sampaio SC, Santos MF, Costa EP, Rangel-Santos AC, Carneiro SM, Curi R, et al. Crotoxin induces actin reorganization and inhibits tyrosine phosphorylation and activity of small GTPases in rat macrophages. Toxicon. 2006;47(8):909–19.
    Rosenfeld G. Método rápido de coloração de esfregaços de sangue. Noções práticas sobre corantes pancrômicos e estudos de diversos fatores. Mem Inst Butantan. 1947;20:315–28.
    Lam FY, Ferrell WR. Inhibition of carrageenan induced inflammation in the rat knee joint by substance P antagonist. Ann Rheum Dis. 1989;48(11):928–32.
    Zambelli VO, Sampaio SC, Sudo-Hayashi LS, Greco K, Britto LR, Alves AS, et al. Crotoxin alters lymphocyte distribution in rats: Involvement of adhesion molecules and lipoxygenase-derived mediators. Toxicon. 2008;51(8):1357–67.
    Yamamoto T, Nozaki-Taguchi N. The role of cyclooxygenase-1 and −2 in the rat formalin test. Anesth Analg. 2002;94(4):962–7.
    Lucas KK, Svensson CI, Hua XY, Yaksh TL, Dennis EA. Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2. Br J Pharmacol. 2005;144(7):940–52.
    Schaeffer EL, Gattaz WF. Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in rats. J Neural Transm (Vienna). 2007;114(3):379–85.
    Cruwys SC, Garrett NE, Perkins MN, Blake DR, Kidd BL. The role of bradykinin B1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br J Pharmacol. 1994;113(3):940–4.
    Daher JB, Souza GE, D’Orléans-Juste P, Rae GA. Endothelin ETB receptors inhibit articular nociception and priming induced by carrageenan in the rat knee-joint. Eur J Pharmacol. 2004;496(1–3):77–85.
    van de Loo FAJ, Bennink MB, Arntz OJ, Smeets RL, Lubberts E, Joosten LAB, et al. Deficiency of NADPH Oxidase Components p47phox and gp91phox Caused Granulomatous Synovitis and Increased Connective Tissue Destruction in Experimental Arthritis Models. Am J Pathol. 2003;163(4):1525–37.
    Picolo G, Cury Y. Peripheral neuronal nitric oxide synthase activity mediates the antinociceptive effect of Crotalus durissus terrificus snake venom, a δ- and κ-opioid receptor agonist. Life Sci. 2004;75(5):559–73.
    Gad SC, Weil CS. Statistics for toxicologists. Principles and Methods of Toxicology. Edited by A. Wallace Hayes. 2nd ed. New York: Raven Press; 1989. p. 435–83.
    Correa D, Lietman SA. Articular cartilage repair: current needs, methods and research directions. Semin Cell Dev Biol. 2016;S1084-9521(16):30208–7.
    Dekkers JS, Schoones JW, Huizinga TW, Toes RE, van der Helm-van Mil AH. Possibilities for preventive treatment in rheumatoid arthritis? Lessons from experimental animal models of arthritis: a systematic literature review and meta-analysis. Ann Rheum Dis. doi: 10.1136/annrheumdis-2016-209830
    Giannotti KC, Leiguez E, Moreira V, Nascimento NG, Lomonte B, Gutiérrez JM, et al. A Lys49 phospholipase A2, isolated from Bothrops asper snake venom, induces lipid droplet formation in macrophages which depends on distinct signaling pathways and the C-terminal region. Biomed Res Int. 2013;2013:807982.
    Moreira V, Gutiérrez JM, Amaral RB, Lomonte B, Purgatto E, Teixeira C. A phospholipase A2 from Bothrops asper snake venom activates neutrophils in culture: Expression of cyclooxygenase-2 and PGE2 biosynthesis. Toxicon. 2011;57(2):288–96.
    Chaves F, León G, Alvarado VH, Gutiérrez JM. Pharmacological modulation of edema induced by Lys-49 and Asp-49 myotoxic phospholipases A2 isolated from the venom of the snake Bothrops asper (terciopelo). Toxicon. 1998;36(12):1861–9.
    Zuliani JP, Gutiérrez JM, Silva LL C e, Sampaio SC, Lomonte B, Pereira Teixeira CF. Activation of cellular functions in macrophages by venom secretory Asp-49 and Lys-49 phospholipases A2. Toxicon. 2005;46(5):523–32.
    Yang Y, Leech M, Hutchinson P, Holdsworth SR, Morand EF. Antiinflammatory effect of lipocortin 1 in experimental arthritis. Inflammation. 1997;21(6):583–96.
    Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646–56.
    Centers for Disease Control and Prevention (CDC). Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation --- United States, 2007–2009. Morb Mortal Wkly Rep. 2010;59(39):1261–5.
    Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272(5258):60–6.
    Ley K, Bullard DC, Arbonés ML, Bosse R, Vestweber D, Tedder TF, et al. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med. 1995;181(2):669–75.
    Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 1993;74(3):541–54.
    Angulo Y, Lomonte B. Inhibitory effect of fucoidan on the activities of crotaline snake venom myotoxic phospholipases A2. Biochem Pharmacol. 2003;66(10):1993–2000.
    Azofeifa K, Angulo Y, Lomonte B. Ability of fucoidan to prevent muscle necrosis induced by snake venom myotoxins: comparison of high- and low-molecular weight fractions. Toxicon. 2008;51(3):373–80.
    Wijewickrama GT, Kim JH, Kim YJ, Abraham A, Oh Y, Ananthanarayanan B, et al. Systematic evaluation of transcellular activities of secretory phospholipases A2: High activity of group V phospholipases A2 to induce eicosanoid biosynthesis in neighboring inflammatory cells. J Biol Chem. 2006;281(16):10935–44.
    Chakraborti S. Phospholipase A2 isoforms: A perspective. Cell Signal. 2003;15(7):637–65.
    Dray A, Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 1993;16(3):99–104.
    Petho G, Reeh PW. Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors. Physiol Rev. 2012;92(4):1699–775.
    Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol. 1992;107(3):660–4.
    Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol. 1991;104(3):765–7.
    Ferreira SH, Lorenzetti BB, Bristow AF, Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature. 1988;334(6184):698–700.
    Nakamura M, Ferreira SH. A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol. 1987;135(2):145–53.
    Poole S, Lorenzetti BB, Cunha JM, Cunha FQ, Ferreira SH. Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br J Pharmacol. 1999;126(3):649–56.
    Ramonda R, Oliviero F, Galozzi P, Frallonardo P, Lorenzin M, Ortolan A, et al. Molecular mechanisms of pain in crystal-induced arthritis. Best Pract Res Clin Rheumatol. 2015;29(1):98–110.
    De Falco L, Fioravanti A, Galeazzi M, Tenti S. Bradykinin and its role in osteoarthritis. Reumatismo. 2013;65(3):97–104.
    Paterson KJ, Zambreanu L, Bennett DLH, McMahon SB. Characterisation and mechanisms of bradykinin-evoked pain in man using iontophoresis. Pain. 2013;154(6):782–92.
    Landucci EC, Toyama M, Marangoni S, Oliveira B, Cirino G, Antunes E, et al. Effect of crotapotin and heparin on the rat paw oedema induced by different secretory phospholipases A2. Toxicon. 2000;38(2):199–208.
    Landucci EC, Castro RC, Pereira MF, Cintra AC, Giglio JR, Marangoni S, et al. Mast cell degranulation induced by two phospholipase A2 homologues: Dissociation between enzymatic and biological activities. Eur J Pharmacol. 1998;343(2–3):257–63.
    Guzzo ML, Farsky SH, De Nucci G, Antunes E, Silva MA, Mello SB. Role of kinins and nitric oxide on the rabbit arthritis induced by Bothrops jararaca venom. Toxicon. 2000;38(11):1535–46.
    Ahlawat A, Rana A, Goyal N, Sharma S. Potential role of nitric oxide synthase isoforms in pathophysiology of neuropathic pain. Inflammopharmacology. 2014;22(5):269–78.
    Lee AS, Ellman MB, Yan D, Kroin JS, Cole BJ, van Wijnen AJ, et al. A current review of molecular mechanisms regarding osteoarthritis and pain. Gene. 2013;527(2):440–7.
    Rose BJ, Kooyman DL. A Tale of Two Joints : The Role of Matrix Metalloproteases in Cartilage Biology. Dis Markers. 2016;2016:4895050. doi: 10.1155/2016/4895050 .
    Thompson C, Davies R, Choy E. Anti cytokine therapy in chronic inflammatory arthritis. Cytokine. 2016;86:92–9.
    Guidelli GM, Barskova T, Brizi MG, Lepri G, Parma A, Talarico R, et al. One year in review: novelties in the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2015;33(1):102–8.
    Mifflin KA, Kerr BJ. Pain in autoimmune disorders. J Neurosci Res. 2016. doi: 10.1002/jnr.23844 .
    Cunha JM, Cunha FQ, Poole S, Ferreira SH. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol. 2000;130(6):1418–24.
    Ferreira SH, Lorenzetti BB, Poole S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol. 1993;110(3):1227–31.
    Zamuner SR, Zuliani JP, Fernandes CM, Gutiérrez JM, Pereira Teixeira CF. Inflammation induced by Bothrops asper venom: release of proinflammatory cytokines and eicosanoids, and role of adhesion molecules in leukocyte infiltration. Toxicon. 2005;46(7):806–13.
    Lomonte B, Tarkowski A, Hanson LA. Host response to Bothrops asper snake venom: Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation. 1993;17(2):93–105.
    Zarpelon AC, Cunha TM, Alves-Filho JC, Pinto LG, Ferreira SH, McInnes IB, et al. IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2. Br J Pharmacol. 2013;169(1):90–101.
    Smith TP, Haymond T, Smith SN, Sweitzer SM. Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic pain. J Pain Res. 2014;7:531–45.
    Forner S, Martini AC, de Andrade EL, Rae GA. Neuropathic pain induced by spinal cord injury: Role of endothelin ETA and ETB receptors. Neurosci Lett. 2016;617:14–21.
    Sin A, Tang W, Wen CY, Chung SK, Chiu KY. The emerging role of endothelin-1 in the pathogenesis of subchondral bone disturbance and osteoarthritis. Osteoarthritis Cartilage. 2015;23(4):516–24.
    Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16(2):109–10.